We are pioneers in harnessing bacteria as a revolutionary new class of medicines – called live biotherapeutics. Founded on over two decades of research, the Company was formed in 2014 and listed on the UK stock market. From the outset, we constructed a library of bacteria isolated from healthy human samples, which now stands at more than 8,000 strains. We have built a drug discovery platform, known as MicroRx, which has show...
We are pioneers in harnessing bacteria as a revolutionary new class of medicines – called live biotherapeutics. Founded on over two decades of research, the Company was formed in 2014 and listed on the UK stock market. From the outset, we constructed a library of bacteria isolated from healthy human samples, which now stands at more than 8,000 strains. We have built a drug discovery platform, known as MicroRx, which has shown the ability to rapidly identify bacteria from our library that have therapeutically relevant effects. To date, the Company has initiated 13 live biotherapeutic programmes across a broad range of diseases.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.